Laurus Labs has scheduled a board meeting for April 30, 2026, to review the financial results for the quarter and year ending March 31, 2026. During the meeting, the directors will also evaluate a proposal for a 2nd Interim Dividend for the fiscal year 2025-26. The company has confirmed that the trading window for designated persons remains closed until May 2, 2026.
Upcoming Board Meeting Details
Laurus Labs Limited has officially announced that its Board of Directors will convene on Thursday, April 30, 2026. The primary objective of this meeting is to review and approve the company’s audited financial performance for the final quarter and the full fiscal year concluding on March 31, 2026.
Dividend Consideration
Beyond the review of financial results, the board will deliberate on a proposal to issue a 2nd Interim Dividend for the current financial year 2025-26. Should the proposal receive approval, the board will also finalize the record date to determine the list of shareholders eligible to receive the dividend payment.
Trading Window Restrictions
In accordance with internal compliance policies, Laurus Labs has restricted trading activities for its Directors and designated personnel. The trading window has been closed since April 1, 2026, and is scheduled to remain inaccessible until the end of the day on Saturday, May 2, 2026, to ensure confidentiality ahead of the earnings release.
Source: BSE
